We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Routine Blood Tests Could Enable Early Detection of COPD

By LabMedica International staff writers
Posted on 06 Aug 2025

Chronic Obstructive Pulmonary Disease (COPD) remains severely underdiagnosed, with approximately 70% of cases going undetected. More...

This is largely due to the challenge of performing the current reference diagnostic test—spirometry—on a large scale. The difficulty of implementing spirometry across the population leads to delayed or missed diagnoses, often resulting in patients seeking care only when the disease has significantly progressed. Late diagnoses also raise the risk of associated conditions such as lung cancer. Now, researchers have identified specific metabolites in the blood of COPD patients that could serve as biomarkers to help detect the disease early and guide individuals toward confirmatory testing.

This discovery was the result of a multicenter study led by the Hospital del Mar Medical Research Institute (IMIM, Barcelona, Spain), CIBER Respiratory Diseases (CIBERES Madrid, Spain), and collaborators. The study analyzed blood samples from 91 patients with COPD and 91 healthy controls, identifying 360 different molecules through mass spectrometry. Out of these, approximately 50 were found to be most relevant, and artificial intelligence (AI) was used to select the ten most effective metabolites for detecting COPD. These metabolites are linked to energy production and lipid metabolism, potentially explaining both fatigue and cardiovascular comorbidities frequently observed in COPD patients. The altered metabolites were measured using standard blood tests, which researchers suggest could be easily adapted into a population-level screening tool.

The findings, published in the International Journal of Molecular Sciences, show that the selected biomarkers had a sensitivity and specificity of over 90% in distinguishing between COPD patients and healthy individuals. This focused set of markers offers a practical pathway to early detection using routine blood tests, which could initiate earlier treatment and closer monitoring of comorbidities. Researchers now plan to validate the efficacy of these biomarkers in a larger and more diverse population, with the goal of integrating the findings into routine clinical practice.

"This could give us a tool for early detection of individuals with COPD, which would allow treatment to begin in the early stages of the disease and enable closer monitoring of potential comorbidities," said IMIM researcher Dr. Joaquim Gea.

Related Links:
IMIM
CIBERES


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
New
Urine Chemistry Control
Dropper Urine Chemistry Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.